PFIZER

Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc.

Pfizer, the world's largest drug maker, is scheduled to appear in court in May over Celebrex, a drug Bingham Young University and researcher Dr. Daniel Simmons claim royalties that could amount to millions to a billion dollars.

Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and freeloading off others in Asia and the United States who are more willing to pay, the boss of Pfizer, the world's largest drugmaker, said.

On Monday, March 12, Pfizer Inc., Johnson & Johnson and Regeneron Pharmaceuticals will argue that they should continue to study the drug, while taking the necessary safety precautions to protect their patients. Two years ago a series experiments to develop a new prescription drug that would successfully alleviate the pain caused by arthritis conducted by some of the world’s biggest pharmaceutical companies were put on hold by the United States’ Food and Drug Administration (FDA).

The Food and Drug Administration rejected an experimental combination cholesterol drug produced by Merck & Co Monday. The experimental drug, known as MK-0653C, hopes to fight heart disease in two different ways, by combining Lipitor and Zetia.

Occupy Wall Street drew a top U.S. security agency's scrutiny, Rolling Stone reported, as protesters across the country tried to revive the movement in a day of action against corporate greed.

Occupy Wall Street roared back to life on Wednesday as ten protesters were arrested in a day of resurgent OWS rallies.

U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, saying they may raise levels of blood sugar and could cause memory loss.

Pharmaceutical company Glenmark Generics issued a recall on Friday for birth control pills norgestimate and ethinyl estradiol tablets due to a packaging error that poses a risk for consumers to become pregnant, just months after a major recall from another drug company.

Seven lots of birth control pills were recalled by Glenmark Generics after a packaging error that could leave the pills ineffective was discovered.

Romney's views on contraception oscillate to fit his political agenda.

It was a rare case where a megalith drug company's error could lead to a truly jarring side effect: pregnancy. Which begs the question: Could Pfizer realistically pay damages as the result of an unexpected pregnancy caused by a recall? Could a suit feasibly force the company to cover the cost of an abortion?

As word spread about the birth control recall of at least one million pill packets in the U.S. from Pfizer on Tuesday, panic ensued amongst women nationwide about their risk of becoming pregnant. But how do you know if the birth control pills you are taking are part of the recall?

Drugmakers Pfizer Inc. (NYSE:PFE) and Eli Lilly & Co. (NYSE:LLY) have seen profits squeezed as lucrative blockbuster drugs came off patent and face competition from low-cost generic drugs. Merck & Co. Inc. (NYSE:MRK) is set to feel the hit in the second half of 2012.

Pfizer Inc is reaching out directly to women consumers to warn them about its U.S. recall of one million packets of birth control pills as concerns mounted that a manufacturing error could raise the risk of unplanned pregnancies.

Pfizer, the world's biggest drug company, appeared Wednesday to have escaped negative investor reaction after announcing a recall of birth-control pills, with stock prices fluctuating throughout the trading session before closing up 13 cents to $21.31.

Pfizer Inc. announced on Tuesday that it will recall at least one million birth control pill packets in the U.S. because they don't prevent pregnancy, the company reported. Here is a full list of the birth control pills affected by the Pfizer recall.

World's largest pharmaceutical company, Pfizer, recalled over 1 million packs of its birth control pills in the United States after they discovered a packaging error, possibly putting women at the risk of unintended pregnancies.

Pfizer said on Tuesday one million packets of birth control pills are being recalled in the U.S. because they weren't made with enough contraceptive to prevent pregnancy. Pfizer learned that the packets either contained too many active tablets or too few -- prompting the massive recall. The problem was caused by mechanical and visual inspection failures on the packaging line, according to The Associated Press.

Merck & Co., the second-largest U.S. drugmaker, is projected to report stronger fourth-quarter profit on double-digit growth of key products, an increasing emerging markets presence and further cost reductions.

Stocks gave up early gains to turn flat on Tuesday, weighed down by mixed corporate earnings and weaker-than-expected data on Midwest business activity and consumer confidence.